Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PET Imaging of Cyclooxygenase in Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating PET imaging of cyclooxygenase in people with multiple sclerosis was terminated; results were posted on 2024-06-27…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Remote Evaluation of MIND Diet [NA]
A clinical trial update indicates a study evaluating the MIND diet's remote evaluation in people with Multiple Sclerosis is currently recrui…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial. [NA]
A randomized trial is evaluating the effects of resistance training in people with multiple sclerosis and is currently recruiting.
-
FDA approval · 2024-06-26FDA Approved: DIMETHYL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the original ANDA for dimethyl fumarate by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women [NA]
A clinical trial is evaluating the efficacy of the alpha-blocker tamsulosin for symptomatic dysuria in women with multiple sclerosis. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Pelvic Floor Disorders in Multiple Sclerosis Patients
An update on a clinical trial examining pelvic floor disorders in patients with multiple sclerosis. The study status indicates NOT_YET_RECRU…
-
FDA approval · 2024-06-21FDA Approved: OCREVUS — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Ocrevus (ocrelizumab) submitted by Genentech, Inc. This marks a supplemental approval of the dru…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 4]
The Phase 4 trial evaluating the radiological onset of action after starting subcutaneous natalizumab in relapsing-remitting multiple sclero…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Cerebellar tDCS and Balance Training in PwMS [NA]
Completed clinical trial evaluating cerebellar transcranial direct current stimulation (tDCS) with balance training in people with multiple …
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS) [NA]
This clinical trial update reports the termination of a study evaluating cognitive remediation augmented with transcranial direct current st…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab
This completed study evaluates the immune response to COVID-19 vaccination in patients with multiple sclerosis treated with ofatumumab.
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies
A completed clinical trial update examining characteristics, adherence, and persistence of disease-modifying therapies in patients with Mult…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis
This trial assessed the effect of cigarette smoke on sleep quality and physical activity in people with Multiple Sclerosis; the study has co…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
This clinical trial update reports the completed results of an all-case investigation evaluating Copaxone (glatiramer acetate) subcutaneous …
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Effect of 12-week FW Programme on Sex Hormone Levels and Risk Factors for MS in Postmenopausal Women [NA]
This completed clinical trial evaluated the effects of a 12-week FW Programme on sex hormone levels and risk factors for multiple sclerosis …
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Effect of Adding Modified Ketogenic Diet to Exercise Program in Treating Obese Patient With Multiple Sclerosis: A Randomized Controlled Trial [NA]
This clinical trial will evaluate whether adding a modified ketogenic diet to an exercise program improves outcomes for obese patients with …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluated low-load blood flow restriction in patients with multiple sclerosis. The update does not provide trial …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
LAPIX Therapeutics announced completion of an observational biomarker study in multiple sclerosis, covering relapsing-remitting and progress…
-
FDA approval · 2024-06-10FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)
FDA approved Genzyme Corporation's supplemental application for AUBAGIO (teriflunomide).
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Enhancing Quality of Life in MS Patients Through Tailored Therapeutic Education [NA]
This clinical trial aims to improve quality of life for people with multiple sclerosis through tailored therapeutic education, and is curren…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Trunk Rehabilitation Compared to Core Stability in Patients With Multiple Sclerosis [NA]
Clinical trial comparing trunk rehabilitation to core stability in people with multiple sclerosis; the study is currently not recruiting.
-
CLINICAL_TRIALS other · 2024-06-06Clinical Trial Update: Next-Gen MS: Feed-forward PRO Data for MS Research
Clinical trial NCT04907305 investigating next-generation patient-reported outcomes data for multiple sclerosis has been terminated.
-
FDA approval · 2024-06-05FDA Approved: PONVORY — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved Janssen's supplemental application for PONVORY (ponesimod), expanding its labeling. The indication relates to treatment of …
-
FDA approval · 2024-06-05FDA Approved: MAYZENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Mayzent (siponimod) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2024-06-05FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation.